The high tumor mRNA expression of POSTN was associated with a significantly worse overall survival (all-time risk of death: HR = 2.3 and 3.8 for patients from the TCGA and CPTAC programs, respectively, Figure 6H) of pancreatic cancer patients. The gene discussed is POSTN; the disease is neoplasm.